Senior Research Scientist
Process development for manufacturing viral-vector based vaccine.
My research investigates improved methods of manufacturing vaccines, including adenovirus vectors. I developed at small scale the manufacturing process which is being used to manufacture a billion doses of the Oxford-AZ COVID-19 vaccine.
Rapid-response manufacturing of adenovirus-vectored vaccines
Joe CCD. et al, (2023), Nature Biotechnology
Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector.
Kingston NJ. et al, (2023), Viruses, 15
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
Joe CCD. et al, (2022), Biotechnology and bioengineering, 119, 48 - 58
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993